Pancreatic cancer trial aims to supercharge immune system before surgery
Disease control
Recruiting now
This phase 2 trial tests whether adding drugs that block the tumor's immune-evasion pathways to standard radiation and immunotherapy can boost the body's immune attack on pancreatic cancer before surgery. About 60 patients with advanced pancreatic cancer who are candidates for su…
Phase: PHASE2 • Sponsor: Gulam Manji • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC